SCHEMBL24632129

SCHEMBL24632129

CCNC(C)CC(C)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.37
SLC6A4 P31645 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26322294 0.82 SIGMAR1 (0.42) SIGMAR1SLC6A4
SCHEMBL62860 0.77
SCHEMBL22738825 0.76
SCHEMBL13595428 0.74 SIGMAR1 (0.31) SIGMAR1
SCHEMBL19380300 0.72
SCHEMBL24248155 0.72 SIGMAR1 (0.37) SIGMAR1SLC6A4
SCHEMBL21142261 0.72 SIGMAR1 (0.37) SIGMAR1SLC6A4
SCHEMBL24236797 0.72 SIGMAR1 (0.37) SIGMAR1SLC6A4
SCHEMBL26322280 0.72
SCHEMBL27339733 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220267380-A1 Glycopeptides Increasing Lipid Synthesis TFCHEM (FR) 2022-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267380-A1 Glycopeptides Increasing Lipid Synthesis CERT1, GALR3, MC1R SIGMAR1 2916/4885SLC6A4 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.